Banking software provider Zeta netted $30m from investors including Mastercard at a $1.5bn valuation while drug development services provider Staq Pharma closed its series C round.
Funding US-headquartered banking software provider Zeta has received $30m in funding from investors including payment services firm Mastercard at a $1.5bn valuation, it disclosed today. The capital will be added to the $240m the company raised from investors including telecoms and internet group SoftBank’s Vision Fund 2 in May 2021, and Zeta founder and CEO…
The rest of this content is only accessible to Global Venturing Subscribers.
This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.
